Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPOX Schuster GmbH is a specialized biotechnology company based in Germany that focuses on the development, production, and application of enzymes for industrial biocatalysis. The company offers an extensive catalog of high-quality enzymes, including lipases, esterases, alcohol dehydrogenases, and nitrilases, which are essential for the sustainable synthesis of pharmaceutical intermediates and fine chemicals. In addition to its product offerings, IPOX Schuster provides contract research services such as enzyme screening, protein engineering, and process development to optimize chemical transformations. By integrating molecular biology with chemical engineering, the company enables its partners to implement efficient, cost-effective, and environmentally friendly manufacturing processes. Their expertise is particularly valuable for the production of chiral molecules and complex organic compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IPOX Schuster.